{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T15:48:35Z","timestamp":1770479315491,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1136\/ard.2004.024927","type":"journal-article","created":{"date-parts":[[2005,3,15]],"date-time":"2005-03-15T20:13:10Z","timestamp":1110917590000},"page":"537-543","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Clinical efficacy of infliximab plus methotrexate in DMARD naive and DMARD refractory rheumatoid arthritis is associated with decreased synovial expression of TNF\u03b1 and IL18 but not CXCL12"],"prefix":"10.1016","volume":"64","author":[{"given":"M","family":"van Oosterhout","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E W N","family":"Levarht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J K","family":"Sont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T W J","family":"Huizinga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R E M","family":"Toes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J M","family":"van Laar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2004.024927_bib1","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/art.1780361206","article-title":"Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha","volume":"36","author":"Elliott","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.024927_bib2","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/S0140-6736(99)05246-0","article-title":"Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group","volume":"354","author":"Maini","year":"1999","journal-title":"Lancet"},{"key":"10.1136\/ard.2004.024927_bib3","doi-asserted-by":"crossref","first-page":"478","DOI":"10.7326\/0003-4819-130-6-199903160-00004","article-title":"Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial","volume":"130","author":"Moreland","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2004.024927_bib4","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJM200011303432202","article-title":"Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group","volume":"343","author":"Lipsky","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2004.024927_bib5","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(04)15640-7","article-title":"Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial","volume":"363","author":"Klareskog","year":"2004","journal-title":"Lancet"},{"key":"10.1136\/ard.2004.024927_bib6","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1002\/1529-0131(200011)43:11<2391::AID-ANR3>3.0.CO;2-F","article-title":"Systemic anti-tumor necrosis factor alpha therapy in rheumatoid arthritis down-regulates synovial tumor necrosis factor alpha synthesis","volume":"43","author":"Ulfgren","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.024927_bib7","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/art.1780390702","article-title":"Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis","volume":"39","author":"Tak","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.024927_bib8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/1529-0131(200001)43:1<38::AID-ANR6>3.0.CO;2-L","article-title":"Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis","volume":"43","author":"Taylor","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.024927_bib9","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/art.10102","article-title":"Stromal cell-derived factor 1 (CXCL12) induces monocyte migration into human synovium transplanted onto SCID mice","volume":"46","author":"Blades","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.024927_bib10","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.4049\/jimmunol.167.3.1644","article-title":"Evidence of IL-18 as a novel angiogenic mediator","volume":"167","author":"Park","year":"2001","journal-title":"J Immunol"},{"key":"10.1136\/ard.2004.024927_bib11","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1136\/ard.61.8.723","article-title":"Anti-tumour necrosis factor (TNF) alpha treatment of rheumatoid arthritis (infliximab) selectively down regulates the production of interleukin (IL) 18 but not of IL12 and IL13","volume":"61","author":"Pittoni","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2004.024927_bib12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.024927_bib13","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis","volume":"38","author":"Prevoo","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.024927_bib14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/art.1780390105","volume":"39","author":"van","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.024927_bib15","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1002\/art.10520","article-title":"Hypoxia-induced production of stromal cell-derived factor 1 (CXCL12) and vascular endothelial growth factor by synovial fibroblasts","volume":"46","author":"Hitchon","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.024927_bib16","doi-asserted-by":"crossref","first-page":"6590","DOI":"10.4049\/jimmunol.165.11.6590","article-title":"Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4+ T cell accumulation in rheumatoid arthritis synovium","volume":"165","author":"Nanki","year":"2000","journal-title":"J Immunol"},{"key":"10.1136\/ard.2004.024927_bib17","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.4049\/jimmunol.170.4.2147","article-title":"Synoviocyte-derived CXCL12 is displayed on endothelium and induces angiogenesis in rheumatoid arthritis","volume":"170","author":"Pablos","year":"2003","journal-title":"J Immunol"},{"key":"10.1136\/ard.2004.024927_bib18","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1002\/art.11219","article-title":"Rheumatoid fibroblast-like synoviocytes overexpress the chemokine stromal cell-derived factor 1 (CXCL12), which supports distinct patterns and rates of CD4+ and CD8+ T cell migration within synovial tissue","volume":"48","author":"Bradfield","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.024927_bib19","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/1529-0131(200201)46:1<130::AID-ART10020>3.0.CO;2-D","article-title":"Stimulation of matrix metalloprotease 3 release from human chondrocytes by the interaction of stromal cell-derived factor 1 and CXC chemokine receptor 4","volume":"46","author":"Kanbe","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.024927_bib20","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1093\/rheumatology\/keg413","article-title":"Michael Mason prize essay 2003. Why do leucocytes accumulate within chronically inflamed joints?","volume":"42","author":"Buckley","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2004.024927_bib21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/jlb.65.2.151","article-title":"The metamorphosis of a molecule: from soluble enzyme to the leukocyte receptor CD38","volume":"65","author":"Ferrero","year":"1999","journal-title":"J Leukoc Biol"},{"key":"10.1136\/ard.2004.024927_bib22","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1046\/j.1365-2141.1996.d01-1811.x","article-title":"A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1","volume":"94","author":"Wijdenes","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1136\/ard.2004.024927_bib23","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/ard.62.5.472","article-title":"Circulating tumour necrosis factor alpha and soluble tumour necrosis factor receptors in patients with different patterns of rheumatoid synovitis","volume":"62","author":"Klimiuk","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2004.024927_bib24","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/ard.2003.012302","article-title":"Tumour necrosis factor {alpha} independent disease mechanisms in rheumatoid arthritis: a histopathological study on the effect of infliximab on rheumatoid nodules","volume":"63","author":"Baeten","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2004.024927_bib25","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/art.10814","article-title":"Association of interleukin-18 expression with enhanced levels of both interleukin-1beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis","volume":"48","author":"Joosten","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.024927_bib26","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1172\/JCI1379","article-title":"Interleukin-18 (IFN gamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells","volume":"101","author":"Puren","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.2004.024927_bib27","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.4049\/jimmunol.171.2.1009","article-title":"IL-18 enhances collagen-induced arthritis by recruiting neutrophils via TNF-alpha and leukotriene B4","volume":"171","author":"Canetti","year":"2003","journal-title":"J Immunol"},{"key":"10.1136\/ard.2004.024927_bib28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/art.1780400206","article-title":"Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity","volume":"40","author":"Tak","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.024927_bib29","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/rheumatology\/37.5.502","article-title":"Methotrexate reduces inflammatory cell numbers, expression of monokines and of adhesion molecules in synovial tissue of patients with rheumatoid arthritis","volume":"37","author":"Dolhain","year":"1998","journal-title":"Br J Rheumatol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724430410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724430410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2004.024927","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T05:21:45Z","timestamp":1737264105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724430410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S0003496724430410"],"URL":"https:\/\/doi.org\/10.1136\/ard.2004.024927","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical efficacy of infliximab plus methotrexate in DMARD naive and DMARD refractory rheumatoid arthritis is associated with decreased synovial expression of TNF\u03b1 and IL18 but not CXCL12","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2004.024927","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Copyright 2005 by Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}